検索ワード: mutanti (マルタ語 - 英語)

frekwenza mutanti :
mutant frequency:

stat tal- ymdd mutanti tal-hbv
ymdd mutant hbv status

it-t[ttxija għall-mutanti
innovation on the policy radar

metodi wżati biex jingħadd in-numru ta' ċelluli viabbli u mutanti,
methods used to enumerate numbers of viable and mutant cells,

fl-immaġinazzjoni popolari, il-mutanti huma ħlejjaq li jinbidlu f’monstri.
in the popular imagination, mutants are creatures which change into monsters.

ma kienx hemm cross resistance bejn foscarnet u cidofovir f’ mutanti magħżula b’ foscarnet.
no cross-resistance between foscarnet and cidofovir was seen with foscarnet-selected mutants.

il-mutanti m184v juru suxxettibbiltà mnaqqsa ħafna għal lamivudine u juru kapaċità replikattiva virali mnaqqsa in vitro.
m184v mutants display greatly reduced susceptibility to lamivudine and show diminished viral replicative capacity in vitro.

l-għadd ta' ċelluli mutanti osservati diviżi bl-għadd ta' ċelluli vijabbli.
the number of mutant cells observed divided by the number of viable cells.

mutanti tal-m184v juru suxxettibiltà mnaqqsa ħafna għal lamivudine u juru tnaqqis tal-ħila replikattiva virali in vitro.
m184v mutants display greatly reduced susceptibility to lamivudine and show diminished viral replicative capacity in vitro.

aktar riżultati mill-prova skond l-istat tal-ymdd mutanti huma miġbura f’tabella 1.
further results from the trial by ymdd mutant status are summarised in table 1.

il-popolazzjoni mutanti ras tikkonsisti minn pazjenti b’mutazzjonijiet kras exon 2 magħrufa kif ukoll b’mutazzjonijiet ras addizzjonali identifikati.
the ras mutant population consists of patients with known kras exon 2 mutations as well as additionally identified ras mutations.

qabel ma jintużaw f'dan it-test, il-kulturi għandhom jitnaddfu minn ċelluli mutanti pre-eżistenti.
prior to use in this test, cultures may need to be cleansed of pre-existing mutant cells.

mutanti ta 'l- m184v juru suxxettibilta' mnaqqsa ħafna għal lamivudine u juru tnaqqis tal- ħila replikattiva virali in vitro.
in

b’mod partikolari, effett negattiv fiż-żieda ta’ cetuximab fil-popolazzjoni mutanti ta’ ras ġie osservat.
in particular a negative effect of cetuximab add-on in the ras mutant population was observed.

mutanti ta' l-m184v juru suxxettibilita' mnaqqsa ħafna għal lamivudine u juru tnaqqis fil-kapaċita' replikattiva virali in vitro.
m184v mutants display greatly reduced susceptibility to lamivudine and show diminished viral replicative capacity in vitro.

l-aħjar trattament għal-pazjenti bil-ymdd mutanti tal-hbv għadu ma ġiex stabbilit (ara sezzjoni 4.4).
the optimal therapeutic management of patients with ymdd mutant hbv has not yet been established (see section 4.4).

mutanti magħżulin b’cidofovir kellhom tibdil ġenetiku fil-ġene tal-polymerase tad-dna u kien hemm cross resistance għal ganciclovir, iżda kienu suxxettibbli għal foscarnet.
cidofovir-selected mutants had a mutation in the dna polymerase gene and were cross-resistant to ganciclovir, but susceptible to foscarnet.